Perspectives on 340B

As legislative efforts have changed the 340 Drug Discount Program, payers, specialty pharmacies and health systems have been impacted. Precision for Value experts Dominic Galante, Chief Medical Officer, and Linda R. Bolland, senior advisor, discuss the factors affecting the program today in an exclusive video on Specialty Pharmacy Continuum.

Watch the video

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.